Identification and validation of a novel five-gene signature in high-risk MYCN-not-amplified neuroblastoma
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Identification and validation of a novel five-gene signature in high-risk MYCN-not-amplified neuroblastoma ; volume:15 ; number:1 ; day:18 ; month:9 ; year:2024 ; pages:1-12 ; date:12.2024
Discover oncology ; 15, Heft 1 (18.9.2024), 1-12, 12.2024
- Creator
-
Wang, Jin-Xia
Zhang, Hong-Yang
Yan, Zi-Jun
Cao, Zi-Yang
Shao, Jing-Bo
Zou, Lin
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s12672-024-01318-0
- URN
-
urn:nbn:de:101:1-2412012112438.867656312726
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:31 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Wang, Jin-Xia
- Zhang, Hong-Yang
- Yan, Zi-Jun
- Cao, Zi-Yang
- Shao, Jing-Bo
- Zou, Lin
- SpringerLink (Online service)
Other Objects (12)
SMAD9-MYCN positive feedback loop represents a unique dependency for MYCN-amplified neuroblastoma
Aurora-A prevents transcription-replication conflicts in MYCN-amplified neuroblastoma
MTHFD1 regulates the NADPH redox homeostasis in MYCN-amplified neuroblastoma
Genomic profile of MYCN non-amplified neuroblastoma and potential for immunotherapeutic strategies in neuroblastoma
Inhibitors of ribosome biogenesis repress the growth of MYCN-amplified neuroblastoma
LRP8‐mediated selenocysteine uptake is a targetable vulnerability in MYCN‐amplified neuroblastoma
Impact of extracellular matrix stiffness on genomic heterogeneity in MYCN-amplified neuroblastoma cell line
Age related gene DST represents an independent prognostic factor for MYCN non-amplified neuroblastoma
The long non-coding RNA MYCNOS-01 regulates MYCN protein levels and affects growth of MYCN-amplified rhabdomyosarcoma and neuroblastoma cells
Transcription factor activating protein 4 is synthetically lethal and a master regulator of MYCN-amplified neuroblastoma
Inhibition of autophagy potentiates the efficacy of Gli inhibitor GANT-61 in MYCN-amplified neuroblastoma cells
Understanding and Exploiting MYCN Addiction in High-Risk Neuroblastoma Using the Example of CDK13
SMAD9-MYCN positive feedback loop represents a unique dependency for MYCN-amplified neuroblastoma
Aurora-A prevents transcription-replication conflicts in MYCN-amplified neuroblastoma
MTHFD1 regulates the NADPH redox homeostasis in MYCN-amplified neuroblastoma
Genomic profile of MYCN non-amplified neuroblastoma and potential for immunotherapeutic strategies in neuroblastoma
Inhibitors of ribosome biogenesis repress the growth of MYCN-amplified neuroblastoma
LRP8‐mediated selenocysteine uptake is a targetable vulnerability in MYCN‐amplified neuroblastoma
Impact of extracellular matrix stiffness on genomic heterogeneity in MYCN-amplified neuroblastoma cell line
Age related gene DST represents an independent prognostic factor for MYCN non-amplified neuroblastoma
The long non-coding RNA MYCNOS-01 regulates MYCN protein levels and affects growth of MYCN-amplified rhabdomyosarcoma and neuroblastoma cells
Transcription factor activating protein 4 is synthetically lethal and a master regulator of MYCN-amplified neuroblastoma
Inhibition of autophagy potentiates the efficacy of Gli inhibitor GANT-61 in MYCN-amplified neuroblastoma cells
Understanding and Exploiting MYCN Addiction in High-Risk Neuroblastoma Using the Example of CDK13
SMAD9-MYCN positive feedback loop represents a unique dependency for MYCN-amplified neuroblastoma
Aurora-A prevents transcription-replication conflicts in MYCN-amplified neuroblastoma
MTHFD1 regulates the NADPH redox homeostasis in MYCN-amplified neuroblastoma
Genomic profile of MYCN non-amplified neuroblastoma and potential for immunotherapeutic strategies in neuroblastoma
Inhibitors of ribosome biogenesis repress the growth of MYCN-amplified neuroblastoma
LRP8‐mediated selenocysteine uptake is a targetable vulnerability in MYCN‐amplified neuroblastoma
Impact of extracellular matrix stiffness on genomic heterogeneity in MYCN-amplified neuroblastoma cell line
Age related gene DST represents an independent prognostic factor for MYCN non-amplified neuroblastoma
The long non-coding RNA MYCNOS-01 regulates MYCN protein levels and affects growth of MYCN-amplified rhabdomyosarcoma and neuroblastoma cells
Transcription factor activating protein 4 is synthetically lethal and a master regulator of MYCN-amplified neuroblastoma
Inhibition of autophagy potentiates the efficacy of Gli inhibitor GANT-61 in MYCN-amplified neuroblastoma cells